Hence all these evidences provide a precious clue that upregulation of AURKA might control the intricate molecular mechanism behind the pathogenesis and development of HCC in individuals with T2DM and might serve as biological marker to detect both diseases at early stages. The gene discussed is AURKA; the disease is hepatocellular carcinoma.